Clinical trials and public trust: the geographical shift to the Asia-Pacific region

被引：3

作者：

Torralba, Karina D. ^{[1
]}

Khan, Nasim A. ^{[2
]}

Quismorio, Francisco P. ^{[1
]}

机构：

[1] Univ So Calif, Div Rheumatol, Keck Sch Med, Los Angeles, CA 90033 USA

[2] Univ Arkansas Med Sci, Div Clin Immunol & Rheumatol, Little Rock, AR 72205 USA

来源：

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2009年 / 12卷 / 03期

关键词：

Asia; clinical trials; ethics; CONFLICT-OF-INTEREST; INDUSTRY; ASSOCIATION;

D O I：

10.1111/j.1756-185X.2009.01409.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Multiple issues surrounding the publication of clinical trials and the conduct of clinical trials, especially those that are industry-sponsored, have raised doubts regarding the integrity of their results, and of the integrity of the medical profession. An appreciation of the historical and economic changes in the relationship between physicians and industry is crucial to the understanding of these issues. Increasingly, as healthcare professionals and centers in the Asia-Pacific region become involved in corporate-funded multi-center drug trials, these ethical issues similarly come into play. It is imperative for medical leaders to take actions ensuring rights of Subjects participating in these clinical trials, and to ensure the integrity of physicians and authors of clinical trials from this region of the world.

引用

页码：186 / 191

页数：6

共 30 条

[1]

Albert T, 2003, HANDLE AUTHORSHIP DI

[2] Association of funding and conclusions in randomized drug trials - A reflection of treatment effect or adverse events? [J].

Als-Nielsen, B ;

Chen, WD ;

Gluud, C ;

Kjaergard, LL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :921-928

[3] The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].

Altman, DG ;

Schulz, KF ;

Moher, D ;

Egger, M ;

Davidoff, F ;

Elbourne, D ;

Gotzsche, PC ;

Lang, T .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694

[4] Industry-sponsored clinical research - A broken system [J].

Angell, Marcia .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (09) :1069-1071

[5]

Angell Marcia., 2005, The Truth about the Drug Companies: How They Deceive Us and What to Do about It

[6]

[Anonymous], International Clinical Trials Registry Platform

[7]

Benatar SR, 2007, INT J TUBERC LUNG D, V11, P617

[8] Factors associated with findings of published trials of drug-drug comparisons: Why some statins appear more efficacious than others [J].

Bero, Lisa ;

Oostvogel, Fieke ;

Bacchetti, Peter ;

Lee, Kirby .

PLOS MEDICINE, 2007, 4 (06) :1001-1010

[9]

Bhandari M, 2004, CAN MED ASSOC J, V170, P477

[10] Industry sponsorship and authorship of clinical trials over 20 years [J].

Buchkowsky, SS ;

Jewesson, PJ .

ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) :579-585

← 1 2 3 →